NASDAQ
No price data available for this timeframe.
Galectin Therapeutics Inc. (GALT) has a market cap of $169.39M as of Friday, May 22, 2026. The GALT market cap is up 8.19% over the past 30 days and has grown 109.38% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.